Report cover image

Dravet Syndrome Market Forecasts to 2032 – Global Analysis By Drug Type (Antiepileptic Drugs [AEDs], Cannabidiol-Based Drugs, Serotonin Modulators and Gene Therapy & Emerging Treatments), Treatment Type (Symptomatic Treatment, Ketogenic Diet and Vagus Ner

Publisher Stratistics Market Research Consulting
Published Sep 15, 2025
Length 200 Pages
SKU # SMR20398559

Description

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Dravet Syndrome Market, By Drug Type
5.1 Introduction
5.2 Antiepileptic Drugs (AEDs)
5.3 Cannabidiol-Based Drugs
5.4 Serotonin Modulators
5.5 Gene Therapy & Emerging Treatments
6 Global Dravet Syndrome Market, By Treatment Type
6.1 Introduction
6.2 Symptomatic Treatment
6.3 Ketogenic Diet
6.4 Vagus Nerve Stimulation (VNS)
7 Global Dravet Syndrome Market, By Seizure Type
7.1 Introduction
7.2 Myoclonic Seizures
7.3 Atonic Seizures
7.4 Partial Seizures
7.5 Tonic-Clonic Seizures
7.6 Other Seizure Types
8 Global Dravet Syndrome Market, By Distribution Channel
8.1 Introduction
8.2 Hospital Pharmacies
8.3 Retail Pharmacies
8.4 Online Pharmacies
9 Global Dravet Syndrome Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Biocodex
11.2 Biogen
11.3 Bright Minds Bio
11.4 Encoded Therapeutics
11.5 Epygenix Therapeutics
11.6 Harmony Biosciences
11.7 Jazz Pharmaceuticals
11.8 Lundbeck
11.9 Marinus Pharmaceuticals
11.10 Meiji Seika Pharma
11.11 Novartis
11.12 Ovid Therapeutics
11.13 Pfizer
11.14 Praxis Precision Medicines
11.15 Stoke Therapeutics
11.16 Supernus Pharmaceuticals
11.17 Takeda Pharmaceutical Company
11.18 UCB
11.19 Xenon Pharmaceuticals
List of Tables
Table 1 Global Dravet Syndrome Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Dravet Syndrome Market Outlook, By Drug Type (2024-2032) ($MN)
Table 3 Global Dravet Syndrome Market Outlook, By Antiepileptic Drugs (AEDs) (2024-2032) ($MN)
Table 4 Global Dravet Syndrome Market Outlook, By Cannabidiol-Based Drugs (2024-2032) ($MN)
Table 5 Global Dravet Syndrome Market Outlook, By Serotonin Modulators (2024-2032) ($MN)
Table 6 Global Dravet Syndrome Market Outlook, By Gene Therapy & Emerging Treatments (2024-2032) ($MN)
Table 7 Global Dravet Syndrome Market Outlook, By Treatment Type (2024-2032) ($MN)
Table 8 Global Dravet Syndrome Market Outlook, By Symptomatic Treatment (2024-2032) ($MN)
Table 9 Global Dravet Syndrome Market Outlook, By Ketogenic Diet (2024-2032) ($MN)
Table 10 Global Dravet Syndrome Market Outlook, By Vagus Nerve Stimulation (VNS) (2024-2032) ($MN)
Table 11 Global Dravet Syndrome Market Outlook, By Seizure Type (2024-2032) ($MN)
Table 12 Global Dravet Syndrome Market Outlook, By Myoclonic Seizures (2024-2032) ($MN)
Table 13 Global Dravet Syndrome Market Outlook, By Atonic Seizures (2024-2032) ($MN)
Table 14 Global Dravet Syndrome Market Outlook, By Partial Seizures (2024-2032) ($MN)
Table 15 Global Dravet Syndrome Market Outlook, By Tonic-Clonic Seizures (2024-2032) ($MN)
Table 16 Global Dravet Syndrome Market Outlook, By Other Seizure Types (2024-2032) ($MN)
Table 17 Global Dravet Syndrome Market Outlook, By Distribution Channel (2024-2032) ($MN)
Table 18 Global Dravet Syndrome Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
Table 19 Global Dravet Syndrome Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
Table 20 Global Dravet Syndrome Market Outlook, By Online Pharmacies (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Table of Contents

200 Pages
1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Emerging Markets 3.7 Impact of Covid-19 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Dravet Syndrome Market, By Drug Type 5.1 Introduction 5.2 Antiepileptic Drugs (AEDs) 5.3 Cannabidiol-Based Drugs 5.4 Serotonin Modulators 5.5 Gene Therapy & Emerging Treatments 6 Global Dravet Syndrome Market, By Treatment Type 6.1 Introduction 6.2 Symptomatic Treatment 6.3 Ketogenic Diet 6.4 Vagus Nerve Stimulation (VNS) 7 Global Dravet Syndrome Market, By Seizure Type 7.1 Introduction 7.2 Myoclonic Seizures 7.3 Atonic Seizures 7.4 Partial Seizures 7.5 Tonic-Clonic Seizures 7.6 Other Seizure Types 8 Global Dravet Syndrome Market, By Distribution Channel 8.1 Introduction 8.2 Hospital Pharmacies 8.3 Retail Pharmacies 8.4 Online Pharmacies 9 Global Dravet Syndrome Market, By Geography 9.1 Introduction 9.2 North America 9.2.1 US 9.2.2 Canada 9.2.3 Mexico 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 Italy 9.3.4 France 9.3.5 Spain 9.3.6 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 New Zealand 9.4.6 South Korea 9.4.7 Rest of Asia Pacific 9.5 South America 9.5.1 Argentina 9.5.2 Brazil 9.5.3 Chile 9.5.4 Rest of South America 9.6 Middle East & Africa 9.6.1 Saudi Arabia 9.6.2 UAE 9.6.3 Qatar 9.6.4 South Africa 9.6.5 Rest of Middle East & Africa 10 Key Developments 10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling 11.1 Biocodex 11.2 Biogen 11.3 Bright Minds Bio 11.4 Encoded Therapeutics 11.5 Epygenix Therapeutics 11.6 Harmony Biosciences 11.7 Jazz Pharmaceuticals 11.8 Lundbeck 11.9 Marinus Pharmaceuticals 11.10 Meiji Seika Pharma 11.11 Novartis 11.12 Ovid Therapeutics 11.13 Pfizer 11.14 Praxis Precision Medicines 11.15 Stoke Therapeutics 11.16 Supernus Pharmaceuticals 11.17 Takeda Pharmaceutical Company 11.18 UCB 11.19 Xenon Pharmaceuticals List of Tables Table 1 Global Dravet Syndrome Market Outlook, By Region (2024-2032) ($MN) Table 2 Global Dravet Syndrome Market Outlook, By Drug Type (2024-2032) ($MN) Table 3 Global Dravet Syndrome Market Outlook, By Antiepileptic Drugs (AEDs) (2024-2032) ($MN) Table 4 Global Dravet Syndrome Market Outlook, By Cannabidiol-Based Drugs (2024-2032) ($MN) Table 5 Global Dravet Syndrome Market Outlook, By Serotonin Modulators (2024-2032) ($MN) Table 6 Global Dravet Syndrome Market Outlook, By Gene Therapy & Emerging Treatments (2024-2032) ($MN) Table 7 Global Dravet Syndrome Market Outlook, By Treatment Type (2024-2032) ($MN) Table 8 Global Dravet Syndrome Market Outlook, By Symptomatic Treatment (2024-2032) ($MN) Table 9 Global Dravet Syndrome Market Outlook, By Ketogenic Diet (2024-2032) ($MN) Table 10 Global Dravet Syndrome Market Outlook, By Vagus Nerve Stimulation (VNS) (2024-2032) ($MN) Table 11 Global Dravet Syndrome Market Outlook, By Seizure Type (2024-2032) ($MN) Table 12 Global Dravet Syndrome Market Outlook, By Myoclonic Seizures (2024-2032) ($MN) Table 13 Global Dravet Syndrome Market Outlook, By Atonic Seizures (2024-2032) ($MN) Table 14 Global Dravet Syndrome Market Outlook, By Partial Seizures (2024-2032) ($MN) Table 15 Global Dravet Syndrome Market Outlook, By Tonic-Clonic Seizures (2024-2032) ($MN) Table 16 Global Dravet Syndrome Market Outlook, By Other Seizure Types (2024-2032) ($MN) Table 17 Global Dravet Syndrome Market Outlook, By Distribution Channel (2024-2032) ($MN) Table 18 Global Dravet Syndrome Market Outlook, By Hospital Pharmacies (2024-2032) ($MN) Table 19 Global Dravet Syndrome Market Outlook, By Retail Pharmacies (2024-2032) ($MN) Table 20 Global Dravet Syndrome Market Outlook, By Online Pharmacies (2024-2032) ($MN) Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us